A study came out this week that I haven't been able to stop thinking about.

Researchers in the Netherlands examined brain tissue from people who had died with confirmed Alzheimer's pathology: the plaques, the tangles, and the damage to the brain. A third of them had never developed dementia. Their cognition had stayed intact, even as the disease progressed inside their brains. The researchers wanted to know why.

What they found was a cluster of rare cells in the brain's memory center, immature neurons that appear to respond differently to Alzheimer's damage depending on the person. In resilient brains, those cells behave differently than in brains that succumb. The study doesn't tell us yet why they behave differently, or what we might do to influence them. However, it confirms something the field has been slow to admit: the disease and the symptoms are not the same thing. The damage doesn't automatically determine the outcome.

That's a truly profound shift from our understanding up until now. Most Alzheimer's research — and most of the grief that follows a diagnosis — operates on the assumption that the pathology is the disease, that once it's there, the trajectory is fixed. That assumption has driven decades of drug trials aimed at clearing plaques. Most of those trials failed. The plaques came out. The symptoms didn't improve.

This study points toward a different question. Not just how do we stop the damage, but what determines whether the brain can live with it.

Keep in mind, this is very early research that will take a long time to manifest into real understanding and treatment. Nobody is translating this into a treatment tomorrow. Treatments probably won’t emerge from this in time to help our loved ones, but this could be wonderful news for the future if the research holds up in further testing.

When my mother has a good day, a sharp moment, something that catches me off guard, I used to file it under fluctuation and brace for what comes next. I think a lot of caregivers do this. It’s how we protect ourselves from the disappointments we’ve had so many times when they return to the inevitable (for now) difficult baseline of confusion. But the research increasingly suggests those moments aren't just noise. The brain doesn't stop adapting because a disease moves in. It keeps working. Some brains, for reasons we're only beginning to understand, work harder than others.

Another article about Northwestern Medical’s SuperAger research, published the same week, found the same thread: the brains that age best are not necessarily the ones with the least damage. They're the ones belonging to people who stayed socially engaged — real relationships, not passive contact.

None of this tells you what to do Thursday afternoon when you're running on four hours of sleep and nobody has called to check on you. But it tells you something true about the brain you're caring for: it is not simply in decline. It's working. And some of them, against everything we thought we understood are holding on.

The Netherlands study and the SuperAger research aren't isolated findings. A few other pieces from recent weeks that follow the same thread:

My mom doesn't know I write this newsletter. But everything in it comes from what I've learned standing next to her. If this was worth something to you, you can tip here.

Leave a tip.